BioTech/Drugs - New York, NY, US
Vice President, Investor Relations and Corporate Communications Protara Therapeutics
R&D Team Administrator, Executive Assistant to Chief Scientific Operations Officer
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead program, TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational, intravenous phospholipid substrate replacement therapy in development for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.
Outlook
WordPress.org
Google Tag Manager
DigitalOcean
Greenhouse.io
Adobe Marketing Cloud